Defibrillator Heart Failure Pacemaker 
JAMA Cardiology
OCTOBER 1, 2024
This randomized clinical trial assesses whether cardioverter-defibrillator implantation is more effective than amiodarone therapy for the primary prevention of all-cause mortality and secondary prevention of sudden cardiac death, hospitalization for heart failure, and use of a pacemaker among patients with chronic Chagas cardiomyopathy.
Dr. Smith's ECG Blog
APRIL 2, 2024
He was defibrillated, but they also noticed that he was being internally defibrillated and then found that he had an implantable ICD. He was unidentified and there were no records available After 7 shocks, he was successfully defibrillated and brought to the ED. Pacemaker mediated tachycardia! There was no bystander CPR.
DAIC
MAY 17, 2024
Based on the Health Data Hub complete medico-administrative database and comprehensive datasets from Implicity's AI -based remote monitoring platform, the Implicity team trained and validated a machine learning algorithm that assesses the risk of future heart failure events, enabling physicians to intervene before a patient requires hospitalization.
Dr. Sanjay Gupta
MAY 23, 2022
Today’s vlog is on the subject of heart failure and in particular on a special type of pacemaker which can make a significant improvement to the quality of life and length of life in patients with heart failure. What is heart failure? You can download this script as a Hindi translation here.
American College of Cardiology
FEBRUARY 6, 2024
The following are key points to remember from a review article on cardiac implantable electronic devices (CIEDs), which include pacemakers for bradycardia, biventricular pacemakers for heart failure, and implantable cardioverter–defibrillators (ICDs) for the treatment of sudden cardiac death:
Dr. Smith's ECG Blog
JANUARY 2, 2025
Place temporary pacemaker 3. Permanent pacer placement Later, a biventricular pacer was placed for " Cardiac Resynchronization Therapy (CRT) " (This is indicated for patients with LBBB and QRS duration > 130 ms and heart failure and vastly improves heart failure). See Dr. Karim's further thoughts on this below.
European Journal of Heart Failure
OCTOBER 22, 2024
Prognostic impact of visit-to-visit changes in heart rate (HR) among patients with heart failure (HF) in the PARADIGM-HF and PARAGON-HF trials. The prognostic implications of HR were consistent across the range of LVEF and observed regardless of -blocker use or presence of a permanent pacemaker.
Expert insights. Personalized for you.
91 
Let's personalize your content